Literature DB >> 18281811

Association of anemia with clinical outcomes in stable coronary artery disease.

Anderson D da Silveira1, Rodrigo A Ribeiro, Ana Paula W Rossini, Steffan F Stella, Henry A R Ritta, Ricardo Stein, Carisi A Polanczyk.   

Abstract

BACKGROUND: Although anemia is pathophysiologically associated with myocardial ischemia, there are scarce data on its clinical impact in patients with stable coronary artery disease on contemporary treatment. This study aims to describe the prevalence of anemia, and its association with symptoms and outcomes in this population.
METHODS: We conducted a prospective cohort study in stable documented coronary artery disease patients. Anemia criteria was hemoglobin (Hb) <12 g/dl in women and <13 g/dl in men. Hemoglobin levels were divided in quartiles (Q) adjusted for sex. Major events included acute coronary syndromes, stroke and cardiovascular deaths. Secondary outcomes were presence of angina and chronic use of nitrates. Cox regression models were used to evaluate the independent effect of anemia on clinical outcomes.
RESULTS: Among 310 patients, 71 (23%) met criteria for anemia. After a mean follow-up of 44+/-23 months, hemoglobin levels had a marked association with occurrence of major events (27% in Q1, 7% in Q2, 8% in Q3 and 12% in Q4; P<0.01). In multivariate analysis, anemia was independently associated with an increased risk of death [hazard ratio (HR) 6.5, 95% confidence interval (1.7-24.2)], major events [HR 3.3 (1.7-6.5)] and revascularization procedures [HR 2.3 (1.3-4.1)]. Persistent of angina symptoms (32 vs. 18%, P=0.01) and chronic use of nitrates (35 vs. 21%, P=0.02) were also more frequent among patients with anemia at baseline.
CONCLUSIONS: In patients with stable ischemic heart disease, presence of anemia, even mild, is associated with a worse prognosis. Strategies aiming at identifying reversible causes of anemia or new treatments should be evaluated in prospective clinical trials.

Entities:  

Mesh:

Year:  2008        PMID: 18281811     DOI: 10.1097/MCA.0b013e3282f27c0a

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  9 in total

1.  Mechanisms responsible for reduced erythropoiesis during androgen deprivation therapy in men with prostate cancer.

Authors:  Thiago Gagliano-Jucá; Karol M Pencina; Tomas Ganz; Thomas G Travison; Philip W Kantoff; Paul L Nguyen; Mary-Ellen Taplin; Adam S Kibel; Zhuoying Li; Grace Huang; Robert R Edwards; Elizabeta Nemeth; Shehzad Basaria
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-10-16       Impact factor: 4.310

2.  Anemia and mortality in older persons: does the type of anemia affect survival?

Authors:  Robert M Shavelle; Ross MacKenzie; David R Paculdo
Journal:  Int J Hematol       Date:  2012-02-21       Impact factor: 2.490

Review 3.  Prevalence of Cardioprotective Medication Use in Coronary Heart Disease Patients in South America: Systematic review and Meta-Analysis.

Authors:  A Marzà-Florensa; E Drotos; P Gulayin; D E Grobbee; V Irazola; K Klipstein-Grobusch; I Vaartjes
Journal:  Glob Heart       Date:  2022-06-08

Review 4.  Threshold haemoglobin levels and the prognosis of stable coronary disease: two new cohorts and a systematic review and meta-analysis.

Authors:  Anoop D Shah; Owen Nicholas; Adam D Timmis; Gene Feder; Keith R Abrams; Ruoling Chen; Aroon D Hingorani; Harry Hemingway
Journal:  PLoS Med       Date:  2011-05-31       Impact factor: 11.069

Review 5.  Management standards for stable coronary artery disease in India.

Authors:  Sundeep Mishra; Saumitra Ray; Jamshed J Dalal; J P S Sawhney; S Ramakrishnan; Tiny Nair; S S Iyengar; V K Bahl
Journal:  Indian Heart J       Date:  2016-12-09

Review 6.  Management Protocols of stable coronary artery disease in India: Executive summary.

Authors:  Sundeep Mishra; Saumitra Ray; Jamshed J Dalal; J P S Sawhney; S Ramakrishnan; Tiny Nair; S S Iyengar; Vinay K Bahl
Journal:  Indian Heart J       Date:  2016 Nov - Dec

7.  The prevalence of anemia in the patients who survived and died due to myocardial infarction (MI).

Authors:  F Fariba; M Moradi; M A Seifrabie
Journal:  J Med Life       Date:  2015

8.  Impact of anemia on in-stent restenosis after percutaneous coronary intervention.

Authors:  Huilin Hu; Shijun Wang; Guanmin Tang; Changlin Zhai; Liang Shen
Journal:  BMC Cardiovasc Disord       Date:  2021-11-19       Impact factor: 2.298

9.  Anemia is a novel predictor for clinical ISR following PCI.

Authors:  Ahmed Hussein; Mohammad Shafiq Awad; Ahlam M Sabra; Hossam Eldin M Mahmoud
Journal:  Egypt Heart J       Date:  2021-05-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.